Soleno Therapeutics (SLNO) Research & Development (2013 - 2026)
Soleno Therapeutics (SLNO) reported Research & Development of $11.3 million for Q1 2026, down 16.59% year-over-year from $13.5 million in Q1 2025, and up 17.95% quarter-over-quarter from $9.6 million in Q4 2025.
Soleno Therapeutics (SLNO) Research & Development (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 14 years of Research & Development data on file, last reported at $11.3 million in Q1 2026.
- Research & Development for Q1 2026 came in at $11.3 million, down 16.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.4 million (down 50.46% YoY), and the FY2025 annual result was $40.6 million, down 48.29% from the prior year.
- Research & Development improved to $11.3 million in Q1 2026 per SLNO's latest filing, from $9.6 million in the prior quarter.
- Over five years, Research & Development peaked at $30.1 million in Q3 2024 and troughed at $3.7 million in Q2 2022.
- A 5-year average of $10.1 million and a median of $8.7 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2024 and 2025: Research & Development jumped 398.73% in 2024, then tumbled 72.11% in 2025.
- A 5-year view of Research & Development shows it stood at $3.8 million in 2022, then soared by 128.06% to $8.7 million in 2023, then soared by 147.28% to $21.5 million in 2024, then tumbled by 55.52% to $9.6 million in 2025, then advanced by 17.95% to $11.3 million in 2026.
- Business Quant data shows SLNO's Research & Development at $11.3 million in Q1 2026, $9.6 million in Q4 2025, and $8.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 11.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.27 Mn |
| Dec 31, 2025 | 9.56 Mn |
| Sep 30, 2025 | 8.41 Mn |
| Jun 30, 2025 | 9.15 Mn |
| Mar 31, 2025 | 13.52 Mn |
| Dec 31, 2024 | 21.49 Mn |
| Sep 30, 2024 | 30.14 Mn |
| Jun 30, 2024 | 12.34 Mn |
| Mar 31, 2024 | 14.60 Mn |
| Dec 31, 2023 | 8.69 Mn |
| Sep 30, 2023 | 6.04 Mn |
| Jun 30, 2023 | 5.14 Mn |
| Mar 31, 2023 | 5.32 Mn |
| Dec 31, 2022 | 3.81 Mn |
| Sep 30, 2022 | 3.77 Mn |
| Jun 30, 2022 | 3.70 Mn |
| Mar 31, 2022 | 3.99 Mn |
| Dec 31, 2021 | 3.73 Mn |
| Sep 30, 2021 | 4.97 Mn |
| Jun 30, 2021 | 5.59 Mn |